Zobrazeno 1 - 10
of 54
pro vyhledávání: '"M V, Kozhevnikova"'
Publikováno v:
Учёные записки Казанского университета: Серия Естественные науки, Vol 166, Iss 4, Pp 704-723 (2024)
Using the JABOWA single-tree growth model, a program was designed to estimate carbon storage dynamics in the aboveground biomass of a mixed forest community. The developed model incorporates the parameters of tree species that are common to the fores
Externí odkaz:
https://doaj.org/article/f0ec3c94821c470daefc846184b99157
Publikováno v:
Georesursy, Vol 23, Iss 3, Pp 8-16 (2024)
This article discusses a possible scenario of energy transition in Russia, taking into account the economic structure, presence of huge oil and gas infrastructure and unique natural resources. All this allows to consider global trends of energy and e
Externí odkaz:
https://doaj.org/article/a91e25fdff6b4e5fac2ab5bede2e07db
Autor:
A. S. Lishuta, O. A. Slepova, N. A. Nikolaeva, M. V. Kozhevnikova, V. Yu. Zektser, A. V. Rustomyan, M. F. Petrukhnova, Yu. N. Belenkov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 6 (2024)
Management of multimorbid patients is challenging, despite advances in pharmacotherapy and widespread use of surgical treatment. The combination of diseases such as coronary artery disease leading to heart failure, hypertension, type 2 diabetes and c
Externí odkaz:
https://doaj.org/article/a93b05ded73a4b32b75be39e2b7df16f
Autor:
S. S. Markin, E. A. Ponomarenko, Yu. A. Romashova, T. O. Pleshakova, S. V. Ivanov, F. N. Bedretdinov, S. L. Konstantinov, A. A. Nizov, A. G. Koledinskii, A. I. Girivenko, K. M. Shestakova, P. A. Markin, N. E. Moskaleva, M. V. Kozhevnikova, Zh. Yu. Chefranova, S. A. Appolonova
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Cardiovascular disease (CVD) represents one of the main causes of mortality worldwide and nearly a half of it is related to ischemic heart disease (IHD). The article represents a comprehensive study on the diagnostics of IHD through the targ
Externí odkaz:
https://doaj.org/article/87f6a3e5d3ef44cea37af3a5a07f2718
Autor:
M. V. Kozhevnikova, E. O. Korobkova, A. V. Krivova, A. V. Kukharenko, N. E. Moskaleva, K. M. Shestakova, N. V. Mesonzhnik, A. A. Ageev, A. A. Boldin, A. Brito, S. А. Appolonova, E. V. Privalova, Y. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 3, Pp 230-239 (2023)
Aim. Branched-chain amino acids (BCAAs) have been postulated as potential indicators of cardiovascular risk. The objective of this study was to explore the relationship between plasma BCAAs and different stages of cardiovascular disorders.Material an
Externí odkaz:
https://doaj.org/article/61c3c7ab4d554143906bdba8748d9c90
Autor:
A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 3, Pp 297-305 (2022)
Aim. To evaluate changes in the profile of aromatic amino acids (AAA) in patients with cardiovascular diseases (CVD): hypertension and coronary artery disease (CАD) in comparison with healthy study participants.Material and methods. One hundred and
Externí odkaz:
https://doaj.org/article/635f8136ef1b4717b3c5152341bfb1f8
Autor:
F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, D. A. Yatsenko, А. V. Emelianov, A. S. Lishuta, N. V. Khabarova, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 3, Pp 408-413 (2021)
Aim. To study the level of serum biomarkers of endothelial dysfunction and myocardial stress in patients with various types of hypertrophic cardiomyopathy (HCM).Material and Methods. 48 patients with hypertrophic cardiomyopathy (27 men and 21 women)
Externí odkaz:
https://doaj.org/article/ba9f82e067fd4a27bdea76adb8b2bd79
Autor:
F. M. Bogatyreva, V. Yu. Kaplunova, M. V. Kozhevnikova, G. A. Shakaryants, E. V. Privalova, Yu. N. Belenkov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 3 (2022)
Aim. To assess the relationship between fibrosis markers and structural and functional parameters in patients with various types of hypertrophic cardiomyopathy (HCM).Material and methods. This prospective comparative non-randomized study included 49
Externí odkaz:
https://doaj.org/article/88221651038545c98eec9fc4c8b2acc1
Autor:
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 3, Pp 328-334 (2019)
Aim. To study some vascular remodeling markers in hypertensive patients depending on the presence of type 2 diabetes mellitus.Material and methods. The study included patients with essential hypertension 1-2 degrees of increase in blood pressure with
Externí odkaz:
https://doaj.org/article/8599c7d6eda940c19466709b6e680653
Autor:
O. O. Voronkova, A. A. Starzhevskaia, V. G. Skachek, E. F. Rogova, G. B. Abdullaeva, O. E. Buyanova, M. V. Kozhevnikova, Yu. N. Belenkov
Publikováno v:
Meditsinskiy sovet = Medical Council. :50-56
The subacute period of coronavirus infection is a 4- to-12-week period after acute illness associated with the SARS-CoV-2 infection. A range of bronchopulmonary symptoms in the subacute period of COVID-19 includes cough, shortness of breath, reduced